Plasmapheresis

PHA Serum products

Plamapheresis, Immunoadsorption, IVIG, MARS, Cytosorb,

32247038 2020. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
32241301 2020. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
C7118608 ä. A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System
32391669 2020. [Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab].
32359878 2020. Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19
32353740 2020. Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2
32258207 2020. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
32361195 ä. SARS-CoV-2 infection complicated by inflammatory syndrome Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
32389697 ä. Plasmapheresis treatment in COVID-19?related autoimmune meningoencephalitis: Case series
32393681 2020. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.
32397847 2020. Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens.
32470601 2020. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
32432784 2020. Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients.
32283154 2020. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.
32426229 2020. Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia.
32454500 2020. Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation.
32505720 2020. Positive Outcome in a COVID-19 patient with Common Variable Immunodeficiency after IVIG.
32585284 2020. Therapeutic Plasma Exchange in Adults with Severe COVID-19 Infection.
32510799 2020. The Application Of Plasmapheresis For Covid-19 Patients.
32501607 2020. Selective C-reactive protein (CRP) apheresis for Covid-19 patients suffering from organ damage.
32552832 2020. First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19.
32414417 2020. Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure.
32534513 2020. COVID-19 Pandemic Hemoperfusion Therapy Versus Plasma Exchange Therapy in Intensive Care.
32590819 2020. Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study.
32561113 2020. Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies.
32380821 2020. Therapeutic plasma exchange as a rescue therapy in patients with coronavirus disease 2019: a case series.
32595974 2020. The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure.

32540345 2020. Anti-SARS-CoV-2 hyperimmune plasma workflow.
32563550 2020. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
32359090 2020. Convalescent plasma: possible therapy for novel coronavirus disease 2019.